At the heart of the healthcare ecosystem

Thuasne® maintains close ties with its ecosystem of healthcare professionals, scientific societies, research centers, and world-renowned experts. This commitment enables the Group to design innovative solutions tailored to the needs of patients.

Ongoing collaboration with healthcare professionals


The expertise of Thuasne® is based on decades of experience and in-depth knowledge of pathologies. As such, the Group regularly shares the latest scientific data on its solutions.

The teams work closely with doctors, physiotherapists, nurses, and research centers to develop solutions that meet practical and clinical requirements. They are in daily contact with pharmacists, orthopedics, orthoprosthetists, and medical equipment stores. This approach ensures appropriate patient care at every stage of treatment.

Thuasne® organizes and - in conjunction with world-renowned experts and learned societies - actively participates in working groups on the major pathologies it treats (the French Society of Vascular Medicine, the American Academy of Orthotists and Prosthetists, the International Society of Lymphology, the French Society of Physical Medicine and Rehabilitation, etc.).

Through these partnerships, public health issues are addressed, resources are pooled to innovate in patient care, and therapeutic needs and emerging treatments are identified.
 

We develop new solutions and indications with medical experts to improve patient care and quality of life
Oliviu CrisanMedical Director

Clinical studies to evaluate the medical service provided

 

At Thuasne®, clinical studies play a central role in the development of innovative medical solutions. Conducted in partnership with healthcare professionals and patient associations, they scientifically validate the efficacy, safety, and therapeutic benefits of solutions being developed or already on the market.

Around twenty studies are currently underway worldwide in various therapeutic fields, such as lymphology, phlebology, rheumatology, and orthopedics.

Publication of clinical studies in reference medical journals is an illustration of this scientific rigor.

Stéphanie Villet, director of clinical studies

Recently published studies

  • OLYMPY

    study on the positive impact of Mobiderm Intimate short in patients with genital lymphedema, published in the Lymphatic Research and Biology Journal.
  • MECASPRY

    study on the benefit of wearing the SpryStep® orthosis in patients who have had a stroke, published in the Journal of Rehabilitation Medicine.

Expertise recognized at scientific congresses

Thuasne® actively participates in national and international scientific events to discuss ideas with opinion leaders on new therapeutic practices. These events are an excellent way to learn about the latest medical advancements and understand the needs of patients and healthcare professionals.

Thanks to its recognized medical and clinical expertise, Thuasne® regularly participates in scientific meetings to present the results of clinical studies conducted by the Group, thereby promoting the efficacy of its medical devices.

This work between the medical department and the clinical trials department helps constantly improve the solutions proposed by Thuasne®.

Supporting the training of healthcare professionals

Thuasne® places medical knowledge at the heart of its commitment. As such, it organizes webinars and has launched the Thuasne® Academy online training platform. Interactive modules, expert-led webinars, customized learning pathways – everything is designed to support continuous, flexible, and readily accessible learning. This provides healthcare professionals with direct access to quality learning material and can deepen their knowledge of pathologies, products, and best practices to provide ever more effective patient care.
Thuasne AcademyThuasne Academy